Literature DB >> 10618064

New monoclonal antibody specific for Candida albicans germ tube.

A Marot-Leblond1, L Grimaud, S Nail, S Bouterige, V Apaire-Marchais, D J Sullivan, R Robert.   

Abstract

Hydrophobic components of the germ tube of the dimorphic pathogenic fungus Candida albicans were used as immunogens to prepare monoclonal antibodies (MAbs). Among the resulting MAbs, one (MAb 16B1-F10) was shown by indirect immunofluorescence to be specific to the surface of the mycelium phase of the C. albicans and C. stellatoidea species. No labeling of any other genera and Candida species tested was observed, including C. dubliniensis, a newly described species which has many phenotypic similarities to C. albicans. This phase-specific epitope resides on a protein moiety. The molecular mass of the antigen released by Zymolyase digestion was determined by gel filtration and ranges from 25 to 166 kDa. The antigen was also shown to be highly hydrophobic. This anti-C. albicans cell wall surface-specific MAb may be a good candidate for use in tests for the rapid differentiation of the two closely related species C. albicans and C. dubliniensis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10618064      PMCID: PMC86019          DOI: 10.1128/JCM.38.1.61-67.2000

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  37 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Use of specialised isolation media for recognition and identification of Candida dubliniensis isolates from HIV-infected patients.

Authors:  A Schoofs; F C Odds; R Colebunders; M Ieven; H Goossens
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-04       Impact factor: 3.267

Review 3.  Candidiasis: the emergence of a novel species, Candida dubliniensis.

Authors:  D C Coleman; D J Sullivan; D E Bennett; G P Moran; H J Barry; D B Shanley
Journal:  AIDS       Date:  1997-04       Impact factor: 4.177

4.  Identification of C3d receptors on Candida albicans.

Authors:  R A Calderone; L Linehan; E Wadsworth; A L Sandberg
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

5.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

6.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

7.  Dynamic expression of cell surface hydrophobicity during initial yeast cell growth and before germ tube formation of Candida albicans.

Authors:  B W Hazen; K C Hazen
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

8.  Rapid identification of Candida dubliniensis by indirect immunofluorescence based on differential localization of antigens on C. dubliniensis blastospores and Candida albicans germ tubes.

Authors:  J Bikandi; R S Millán; M D Moragues; G Cebas; M Clarke; D C Coleman; D J Sullivan; G Quindós; J Pontón
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

9.  Characterization of binding of human fibrinogen to the surface of germ-tubes and mycelium of candida albicans.

Authors:  A Bouali; R Robert; G Tronchin; J M Senet
Journal:  J Gen Microbiol       Date:  1987-03

10.  Cell surface antigens of human malignant melanoma: definition of six antigenic systems with mouse monoclonal antibodies.

Authors:  W G Dippold; K O Lloyd; L T Li; H Ikeda; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

View more
  7 in total

1.  Development and evaluation of a rapid latex agglutination test using a monoclonal antibody to identify Candida dubliniensis colonies.

Authors:  Agnes Marot-Leblond; Bertrand Beucher; Sandrine David; Sandrine Nail-Billaud; Raymond Robert
Journal:  J Clin Microbiol       Date:  2006-01       Impact factor: 5.948

2.  Differentiation of Candida albicans and Candida dubliniensis by using recombinant human antibody single-chain variable fragments specific for hyphae.

Authors:  Joseph M Bliss; Mark A Sullivan; Jane Malone; Constantine G Haidaris
Journal:  J Clin Microbiol       Date:  2003-03       Impact factor: 5.948

3.  Evaluation of a rapid immunochromatographic assay for identification of Candida albicans and Candida dubliniensis.

Authors:  Agnes Marot-Leblond; Linda Grimaud; Sandrine David; Derek J Sullivan; David C Coleman; Jose Ponton; Raymond Robert
Journal:  J Clin Microbiol       Date:  2004-11       Impact factor: 5.948

4.  Recognition of Candida albicans Als3 by the germ tube-specific monoclonal antibody 3D9.3.

Authors:  Bertrand Beucher; Agnès Marot-Leblond; Sandrine Billaud-Nail; Soon-Hwan Oh; Lois L Hoyer; Raymond Robert
Journal:  FEMS Immunol Med Microbiol       Date:  2009-04

5.  Beta-1,2- and alpha-1,2-linked oligomannosides mediate adherence of Candida albicans blastospores to human enterocytes in vitro.

Authors:  Fredéric Dalle; Thierry Jouault; Pierre André Trinel; Jacques Esnault; Jean Maurice Mallet; Philippe d'Athis; Daniel Poulain; Alain Bonnin
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

6.  Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study.

Authors:  A M Tortorano; J Peman; H Bernhardt; L Klingspor; C C Kibbler; O Faure; E Biraghi; E Canton; K Zimmermann; S Seaton; R Grillot
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-03-17       Impact factor: 3.267

7.  Depletion of a polo-like kinase in Candida albicans activates cyclase-dependent hyphal-like growth.

Authors:  Catherine Bachewich; David Y Thomas; Malcolm Whiteway
Journal:  Mol Biol Cell       Date:  2003-02-21       Impact factor: 4.138

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.